Efficacy and safety of autoinjected exenatide once‐weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION‐NEO‐2 randomized clinical study
Kishore M. Gadde; Marion L. Vetter; Nayyar Iqbal; Elise Hardy; Peter Öhman
Author Information: Pennington Biomedical Research Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.